Dr. David Samadi, Urology Expert, Discusses Mitt Romney’s Prostate Cancer Prognosis

February 22, 2018

For any politician, their health and health prognosis is something that will concern voters on election day. With having recently disclosed a bout with a prostate tumor, and the tumor’s subsequent surgical removal, voters should rest assured regarding Romney’s health outcomes upon reading Dr. David Samadi’s recent article regarding prostate cancer, treatment options, and survival outcomes.

Dr. David Samadi, an innovative and respected physician, discusses that by choosing surgery, Romney likely chose the safer option for long term health. Readers should feel at ease and trust Dr. David Samadi’s assessment. A driven and ambitious man, his article is informed by years of study and practice. Having completed his medical studies at S.U.N.Y., Stony Brook School of Medicine, his degree and work experience should more than speak for itself. Currently a Professor of Urology at Hofstra North Shore-LIJ School of Medicine and Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital in New York City, Dr. David Samadi’s appraisal of Romney’s actions in choosing to surgically remove the tumor avoids the potential complication of cancer in adjacent organs that could result when treating with radiation. While surgery may not always be an option as explained by Dr. David Samadi, any respectable surgeon will thoroughly discuss the best option for that particular patient.

Romney’s experience with prostate cancer may not apply to all men who develop prostate cancer, but Dr. David Samadi shares information in this article that is useful for many men to heed. In 2018, it is likely that many men will go through the same experience that Romney worked through. The American Cancer Society is anticipating approximately 164,690 new cases of prostate cancer in the upcoming year. Those who are diagnosed would benefit from reading Dr. David Samadi’s works to educate themselves on prostate cancer and work with their doctor to develop the best action plan for their prognosis.

Overall, voters can be satisfied that Mitt Romney’s bout with prostate cancer will not effect his ability to serve as a Senate representative in Utah. Many other politicians have chosen the same route as Romney, and have proceeded on to continue to serve the country for many years after. With such an expert as this reviewing his case, voters can feel secure in that should Romney run, that this health issue will not impede his ability to lead and represent their interests.

Dr. David Samadi’s Facebook Page: www.facebook.com/DrDavidSamadi/